BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/26/2024 10:17:47 AM | Browse: 34 | Download: 244
 |
Received |
|
2024-06-05 11:28 |
|
Peer-Review Started |
|
2024-06-05 11:28 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-07-02 05:35 |
|
Revised |
|
2024-08-07 14:57 |
|
Second Decision |
|
2024-08-12 05:15 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-08-12 09:31 |
|
Articles in Press |
|
2024-08-12 09:31 |
|
Publication Fee Transferred |
|
2024-08-14 12:20 |
|
Edit the Manuscript by Language Editor |
|
2024-08-22 21:00 |
|
Typeset the Manuscript |
|
2024-08-29 03:19 |
|
Publish the Manuscript Online |
|
2024-09-26 10:17 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Small particle drug-eluting beads-transarterial chemoembolization combined with targeted therapy in the clinical treatment of unresectable liver cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Song Qi, Peng Zhao, Xiao-Bo Zhao, Yong-Li Zhao and Ying-Chang Guo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jing-Song Qi, MMed, Associate Chief Physician, Department of Interventional, The First Affiliated Hospital of Xinxiang Medical University, No. 88 Jiankang Road, Weihui, Xinxiang 453100, Henan Province, China. jingsong05010403@163.com |
| Key Words |
Small particle; Drug-eluting beads-transarterial chemoembolization; Sorafenib; Treatment; Unresectable liver cancer |
| Core Tip |
This study compared the efficacy of single-agent sorafenib targeted therapy with its combination with small particle drug-eluting beads-transarterial chemoembolization (DEB-TACE) in patients with unresectable liver cancer. The results demonstrate that combining small particle DEB-TACE with sorafenib significantly enhances both short- and long-term treatment outcomes compared to single-agent therapy. This combination approach improves liver function, reduces tumor marker levels, boosts overall treatment efficacy, and enhances patient prognosis. This approach is safe, reliable, and holds significant clinical utility. |
| Publish Date |
2024-09-26 10:17 |
| Citation |
<p>Qi JS, Zhao P, Zhao XB, Zhao YL, Guo YC. Small particle drug-eluting beads-transarterial chemoembolization combined with targeted therapy in the clinical treatment of unresectable liver cancer. <i>World J Gastrointest Oncol</i> 2024; 16(10): 4157-4165</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i10/4157.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i10.4157 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
